author-photo

John M. Millholland

Novartis

7

Papers

9

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Therapy-relevant gene signatures in the high risk localized renal cell carcinoma setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
Abstract 5640: Targeting tumor-promoting inflammation (TPI) via the IL-1βpathway for cancer immunotherapy

2020 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Serum biomarkers of inflammation (ferritin, IL-8, TNFR1) and outcomes in BOLERO-2, a phase III trial of HR+/HER2- metastatic breast cancer treated with everolimus (mTOR inhibitor).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract C103: Targeting IL-1β pathway for cancer immunotherapy

2019 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)